Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6457 - 6464 of 12007 results

Supreme Court Hears Oral Arguments in Oil States Regarding Constitutional Challenge to Inter Partes Review
December 8, 2017| Blog| Viewpoint

After Schiano: Lessons For Athletic Directors from Tennessee’s Coaching Search
December 7, 2017| Blog| Viewpoint

Bitcoin Experts See Prices Surging as High as $100,000 One Year From Now
December 7, 2017| News

Is Ephemeral Messaging an Evidence Foul? Not Necessarily
December 7, 2017| News

When is a Copyright “Registered” for Purposes of Filing Suit?
December 6, 2017| Blog| Viewpoint

Revived Travel Ban Puts Employers, Immigrants In A Bind
December 6, 2017| News

Proposed Medicare Advantage and Part D Regulations for CY 2019 – CMS Takes on the Opioid Epidemic
December 5, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.
Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|

Health Law Diagnosed: PBM Update Spring 2025
June 10, 2025| Podcast|
